Yuji Sagara
Nagasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Detection of Novel Urine Markers Using Immune Complexome Analysis in Bladder Cancer Patients: A Preliminary Study.
Journal: In vivo (Athens, Greece)
Published: March 13, 2021
Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer.
Journal: Medicines (Basel, Switzerland)
Published: July 09, 2018
High Consumption of Green Tea Suppresses Urinary Tract Recurrence of Urothelial Cancer via Down-regulation of Human Antigen-R Expression in Never Smokers.
Journal: In vivo (Athens, Greece)
Published: March 31, 2018
Pathological significance and prognostic roles of densities of CD57+ cells, CD68+ cells, and mast cells, and their ratios in clear cell renal cell carcinoma.
Journal: Human pathology
Published: February 26, 2018
A Mini-Review of Reactive Oxygen Species in Urological Cancer: Correlation with NADPH Oxidases, Angiogenesis, and Apoptosis.
Journal: International journal of molecular sciences
Published: September 18, 2017
Renoprotective effects of telmisartan after unilateral renal ablation in rats.
Journal: International journal of nephrology and renovascular disease
Published: October 22, 2013
CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34.
Journal: Virchows Archiv : an international journal of pathology
Published: January 14, 2013
Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysis.
Journal: Cancer chemotherapy and pharmacology
Published: March 22, 2012
Effect of maintenance chemotherapy with gemcitabine and paclitaxel on recurrent squamous cell carcinoma of the bladder: a case report.
Journal: Anticancer research
Published: December 27, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026